By Deirdra Funcheon
When Nicholas Mastroianni II appeared on stage at a real estate forum in Shanghai in 2016, the other panelists -- including ex-New York governor George Pataki – deferred to him as the expert on the U.S. government’s EB-5 program, which allows foreign investors
By Fred Schulte
Kaiser Health News
Six months after hiring former New York City mayor Rudy Giuliani’s consulting firm, Purdue Pharma settled a Florida state investigation that had threatened to expose early illegal marketing of its blockbuster drug OxyContin, company and state records show.
On Oct. 26, 2005, Alfred Caronia, a sales consultant for a little-known pharmaceutical company based in California, met with a doctor to discuss promotion of one of the firm’s drugs.
The drug, a depressant called Xyrem, had been approved by the U.S. Food and Drug Administration to treat only certain patients with the sleep disorder narcolepsy. But Caronia maintained, in a conversation with a doctor that was recorded by federal investigators, that the drug could be used to treat an array of other sleep and muscle ailments.
By Dan Christensen
Two months after Florida Gov. Rick Scott helped then-Indiana Gov. Mike Pence fundraise in Fort Lauderdale last year, Pence announced a $650,000 incentives package for a company owned in large part by Scott.
By Francisco Alvarado
From last July to March, the campaign committee for freshman Florida Congressman Francis Rooney paid roughly $117,000 to the former law firm of White House Counsel Donald McGahn II. However, neither Rooney nor McGahn are answering questions about the payments.